Keyword: Becton Dickinson

5. Becton Dickinson

While most of 2024’s 10 largest medtech companies are projected to hold steady in their positions, BD is set to break from the pack in the coming years—leapfrogging three companies to take a spot in the top five, after its late-2017 acquisition of C.R. Bard.
operating room

Special Report—The top 10 medtech companies of 2024

While most of the world’s top 10 medtech companies are expected to defend their relative rankings in the coming years, ambitious or inspired M&A deals could give companies lower on the list the oomph to move up and reap billions in additional sales in new market segments.
Becton Dickinson

8. Becton Dickinson

Between its $12 billion deal to acquire CareFusion in 2014 and a $24 billion deal to buy C.R. Bard, Becton Dickinson made some key offloads and is investing $100 million in its Nebraska plant to boost its insulin syringe manufacturing.